p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications
Abstract Background The risk of diabetic complications is modified by genetic and epigenetic factors. p66Shc drives the hyperglycaemic cell damage and its deletion prevents experimental diabetic complications. We herein tested whether p66Shc expression in peripheral blood mononuclear cells (PBMCs) p...
Main Authors: | Gian Paolo Fadini, Mattia Albiero, Benedetta Maria Bonora, Nicol Poncina, Saula Vigili de Kreutzenberg, Angelo Avogaro |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12933-018-0660-9 |
Similar Items
-
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial
by: Benedetta Maria Bonora, et al.
Published: (2019-08-01) -
Silent coronary artery disease in type 2 diabetes: a narrative review on epidemiology, risk factors, and clinical studies
by: Saula Vigili de Kreutzenberg
Published: (2021-02-01) -
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study
by: Mario Luca Morieri, et al.
Published: (2019-09-01) -
Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets’ attainment in subjects with and without type 2 diabetes
by: Mario Luca Morieri, et al.
Published: (2021-07-01) -
The p66<sup>Shc</sup> Redox Protein and the Emerging Complications of Diabetes
by: Giuseppina Biondi, et al.
Published: (2023-12-01)